UCSF

Tagged: TRANSPERS

Research outlines challenges for adoption of new genetic tests

Every day, on average, ten new genetic tests become commercially available to help doctors and patients make more informed decisions about health care.

Phillips discusses insurance coverage for genomic testing

Kathryn Phillips, PhD, discusses insurance coverage for genomic testing in her recent articles published in JAMA and Science.

Study identifies lack of information about HER2 testing practices

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...